Manufacturing - Tools & Accessories
Compare Stocks
3 / 10Stock Comparison
SCAG vs NIO vs XPEV
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Manufacturers
Auto - Manufacturers
SCAG vs NIO vs XPEV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Manufacturing - Tools & Accessories | Auto - Manufacturers | Auto - Manufacturers |
| Market Cap | $6M | $12.28B | $5.42B |
| Revenue (TTM) | $0.00 | $69.42B | $60.29B |
| Net Income (TTM) | $-215K | $-24.31B | $-4.28B |
| Gross Margin | — | 10.3% | 15.7% |
| Operating Margin | — | -32.6% | -8.9% |
| Total Debt | $3M | $33.82B | $15.94B |
| Cash & Equiv. | $769.00 | $19.33B | $18.59B |
SCAG vs NIO vs XPEV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Scage Future Americ… (SCAG) | 100 | 9.3 | -90.7% |
| NIO Inc. (NIO) | 100 | 171.1 | +71.1% |
| XPeng Inc. (XPEV) | 100 | 87.0 | -13.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCAG vs NIO vs XPEV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SCAG has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 13.7% margin vs NIO's -35.0%
- -2.1% ROA vs NIO's -23.7%
NIO is the clearest fit if your priority is income & stability and long-term compounding.
- beta 1.29
- -11.1% 10Y total return vs XPEV's -26.7%
- Beta 1.29, current ratio 0.99x
XPEV is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 33.2%, EPS growth 48.7%, 3Y rev CAGR 24.9%
- Lower volatility, beta 1.39, Low D/E 51.0%, current ratio 1.25x
- 33.2% revenue growth vs SCAG's -100.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 33.2% revenue growth vs SCAG's -100.0% | |
| Quality / Margins | 13.7% margin vs NIO's -35.0% | |
| Stability / Safety | Beta 1.29 vs SCAG's 1.42 | |
| Dividends | Tie | None of these 3 stocks pay a meaningful dividend |
| Momentum (1Y) | +52.9% vs SCAG's -94.4% | |
| Efficiency (ROA) | -2.1% ROA vs NIO's -23.7% |
SCAG vs NIO vs XPEV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SCAG vs NIO vs XPEV — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
XPEV leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NIO and SCAG operate at a comparable scale, with $69.4B and $0 in trailing revenue. XPEV is the more profitable business, keeping -7.1% of every revenue dollar as net income compared to NIO's -35.0%. On growth, XPEV holds the edge at +125.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $0 | $69.4B | $60.3B |
| EBITDAEarnings before interest/tax | -$215,486 | -$23.0B | -$3.9B |
| Net IncomeAfter-tax profit | -$215,486 | -$24.3B | -$4.3B |
| Free Cash FlowCash after capex | -$877,920 | -$16.5B | $0 |
| Gross MarginGross profit ÷ Revenue | — | +10.3% | +15.7% |
| Operating MarginEBIT ÷ Revenue | — | -32.6% | -8.9% |
| Net MarginNet income ÷ Revenue | — | -35.0% | -7.1% |
| FCF MarginFCF ÷ Revenue | — | -23.8% | -10.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +9.0% | +125.3% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +7.6% | +63.2% |
Valuation Metrics
SCAG leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $6M | $12.3B | $5.4B |
| Enterprise ValueMkt cap + debt − cash | $9M | $14.4B | $5.0B |
| Trailing P/EPrice ÷ TTM EPS | -28.18x | -3.62x | -17.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | — |
| Price / SalesMarket cap ÷ Revenue | — | 1.27x | 0.90x |
| Price / BookPrice ÷ Book value/share | 1.19x | 6.08x | 3.20x |
| Price / FCFMarket cap ÷ FCF | — | — | — |
Profitability & Efficiency
XPEV leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SCAG delivers a -4.2% return on equity — every $100 of shareholder capital generates $-4 in annual profit, vs $-3 for NIO. XPEV carries lower financial leverage with a 0.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to NIO's 2.50x. On the Piotroski fundamental quality scale (0–9), XPEV scores 4/9 vs NIO's 3/9, reflecting mixed financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | -4.2% | -2.7% | -13.8% |
| ROA (TTM)Return on assets | -2.1% | -23.7% | -5.0% |
| ROICReturn on invested capital | — | -55.2% | -16.9% |
| ROCEReturn on capital employed | -108.3% | -41.7% | -14.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 4 |
| Debt / EquityFinancial leverage | 0.56x | 2.50x | 0.51x |
| Net DebtTotal debt minus cash | $3M | $14.5B | -$2.6B |
| Cash & Equiv.Liquid assets | $769 | $19.3B | $18.6B |
| Total DebtShort + long-term debt | $3M | $33.8B | $15.9B |
| Interest CoverageEBIT ÷ Interest expense | — | -25.29x | -10.29x |
Total Returns (Dividends Reinvested)
Evenly matched — NIO and XPEV each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XPEV five years ago would be worth $5,826 today (with dividends reinvested), compared to $556 for SCAG. Over the past 12 months, NIO leads with a +52.9% total return vs SCAG's -94.4%. The 3-year compound annual growth rate (CAGR) favors XPEV at 13.8% vs SCAG's -61.8% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | -58.7% | +14.2% | -23.9% |
| 1-Year ReturnPast 12 months | -94.4% | +52.9% | -18.9% |
| 3-Year ReturnCumulative with dividends | -94.4% | -29.0% | +47.4% |
| 5-Year ReturnCumulative with dividends | -94.4% | -84.1% | -41.7% |
| 10-Year ReturnCumulative with dividends | -94.4% | -11.1% | -26.7% |
| CAGR (3Y)Annualised 3-year return | -61.8% | -10.8% | +13.8% |
Risk & Volatility
NIO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NIO is the less volatile stock with a 1.29 beta — it tends to amplify market swings less than SCAG's 1.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NIO currently trades 73.2% from its 52-week high vs SCAG's 3.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.42x | 1.29x | 1.39x |
| 52-Week HighHighest price in past year | $24.47 | $8.02 | $28.24 |
| 52-Week LowLowest price in past year | $0.80 | $3.34 | $15.38 |
| % of 52W HighCurrent price vs 52-week peak | +3.4% | +73.2% | +55.1% |
| RSI (14)Momentum oscillator 0–100 | 32.2 | 44.3 | 40.2 |
| Avg Volume (50D)Average daily shares traded | 9K | 39.7M | 6.4M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: NIO as "Buy", XPEV as "Buy". Consensus price targets imply 64.0% upside for XPEV (target: $26) vs 9.9% for NIO (target: $6).
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $6.45 | $25.50 |
| # AnalystsCovering analysts | — | 24 | 17 |
| Dividend YieldAnnual dividend ÷ price | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +100.0% | 0.0% | 0.0% |
XPEV leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SCAG leads in 1 (Valuation Metrics). 1 tied.
SCAG vs NIO vs XPEV: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is SCAG or NIO or XPEV a better buy right now?
For growth investors, XPeng Inc.
(XPEV) is the stronger pick with 33. 2% revenue growth year-over-year, versus -100. 0% for Scage Future American Depositary Shares (SCAG). Analysts rate NIO Inc. (NIO) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SCAG or NIO or XPEV?
Over the past 5 years, XPeng Inc.
(XPEV) delivered a total return of -41. 7%, compared to -94. 4% for Scage Future American Depositary Shares (SCAG). Over 10 years, the gap is even starker: NIO returned -11. 1% versus SCAG's -94. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SCAG or NIO or XPEV?
By beta (market sensitivity over 5 years), NIO Inc.
(NIO) is the lower-risk stock at 1. 29β versus Scage Future American Depositary Shares's 1. 42β — meaning SCAG is approximately 10% more volatile than NIO relative to the S&P 500. On balance sheet safety, XPeng Inc. (XPEV) carries a lower debt/equity ratio of 51% versus 3% for NIO Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — SCAG or NIO or XPEV?
By revenue growth (latest reported year), XPeng Inc.
(XPEV) is pulling ahead at 33. 2% versus -100. 0% for Scage Future American Depositary Shares (SCAG). On earnings-per-share growth, the picture is similar: Scage Future American Depositary Shares grew EPS 73. 1% year-over-year, compared to 11. 3% for NIO Inc.. Over a 3-year CAGR, XPEV leads at 24. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SCAG or NIO or XPEV?
Scage Future American Depositary Shares (SCAG) is the more profitable company, earning 0.
0% net margin versus -34. 5% for NIO Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SCAG leads at 0. 0% versus -33. 3% for NIO. At the gross margin level — before operating expenses — XPEV leads at 14. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SCAG or NIO or XPEV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SCAG or NIO or XPEV better for a retirement portfolio?
For long-horizon retirement investors, NIO Inc.
(NIO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 29)). Both have compounded well over 10 years (NIO: -11. 1%, SCAG: -94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SCAG and NIO and XPEV?
These companies operate in different sectors (SCAG (Industrials) and NIO (Consumer Cyclical) and XPEV (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SCAG is a small-cap quality compounder stock; NIO is a mid-cap high-growth stock; XPEV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.